Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) — Cash Flow-to-Debt Ratio
Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) has a Cash Flow-to-Debt Ratio of 0.28x as of March 2026, meaning its operating cash flow of TL180.45 Million could theoretically repay 0% of its total liabilities (TL648.60 Million) in one year. See Meditera Tibbi Malzeme Sanayi ve Ticaret (MEDTR) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Meditera Tibbi Malzeme Sanayi ve Ticaret AS Cash Flow-to-Debt Ratio (2018–2025)
Historical debt coverage capacity for Meditera Tibbi Malzeme Sanayi ve Ticaret AS across 8 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Meditera Tibbi Malzeme Sanayi ve Ticaret.
Annual Cash Flow-to-Debt Ratio for Meditera Tibbi Malzeme Sanayi ve Ticaret AS (2018–2025)
Year-by-year debt coverage analysis for Meditera Tibbi Malzeme Sanayi ve Ticaret AS. Check Meditera Tibbi Malzeme Sanayi ve Ticaret (MEDTR) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (TRY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.66x | TL435.35 Million | TL661.10 Million | ▼ -36.5% |
| 2024 | 1.04x | TL780.69 Million | TL752.75 Million | ▼ -22.8% |
| 2023 | 1.34x | TL801.02 Million | TL596.54 Million | ▲ +5492.3% |
| 2022 | 0.02x | TL5.10 Million | TL212.41 Million | ▼ -90.2% |
| 2021 | 0.24x | TL36.64 Million | TL149.84 Million | ▼ -58.4% |
| 2020 | 0.59x | TL73.26 Million | TL124.53 Million | ▲ +175.6% |
| 2019 | 0.21x | TL20.01 Million | TL93.72 Million | ▼ -72.2% |
| 2018 | 0.77x | TL73.26 Million | TL95.36 Million | — |